Detalhe da pesquisa
1.
Real-world experience with calcitonin gene-related peptide-targeted antibodies for migraine prevention: a retrospective observational cohort study at two Japanese headache centers.
BMC Neurol
; 24(1): 32, 2024 Jan 18.
Artigo
em Inglês
| MEDLINE | ID: mdl-38238659
2.
Characterizing gaps in the preventive pharmacologic treatment of migraine: Multi-country results from the CaMEO-I study.
Headache
; 64(5): 469-481, 2024 May.
Artigo
em Inglês
| MEDLINE | ID: mdl-38706199
3.
Label-Free Liquid Chromatography-Mass Spectrometry Quantitation of Relative N- and O-Glycan Concentrations in Human Milk in Japan.
Int J Mol Sci
; 25(3)2024 Feb 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-38339050
4.
Diagnosis, knowledge, perception, and productivity impact of headache education and clinical evaluation program in the workplace at an information technology company of more than 70,000 employees.
Cephalalgia
; 43(4): 3331024231165682, 2023 04.
Artigo
em Inglês
| MEDLINE | ID: mdl-36967710
5.
Chronic Migraine Epidemiology and Outcomes - International (CaMEO-I) Study: Methods and multi-country baseline findings for diagnosis rates and care.
Cephalalgia
; 43(6): 3331024231180611, 2023 06.
Artigo
em Inglês
| MEDLINE | ID: mdl-37314231
6.
A study to investigate the prevalence of headache disorders and migraine among people registered in a health insurance association in Japan.
J Headache Pain
; 23(1): 70, 2022 Jun 23.
Artigo
em Inglês
| MEDLINE | ID: mdl-35733104
7.
Phase 2 randomized placebo-controlled study of lasmiditan for the acute treatment of migraine in Japanese patients.
Headache
; 61(5): 755-765, 2021 May.
Artigo
em Inglês
| MEDLINE | ID: mdl-33990951
8.
Long-term efficacy and safety during open-label erenumab treatment in Japanese patients with episodic migraine.
Headache
; 61(4): 653-661, 2021 Apr.
Artigo
em Inglês
| MEDLINE | ID: mdl-33764538
9.
Erenumab treatment for migraine prevention in Japanese patients: Efficacy and safety results from a Phase 3, randomized, double-blind, placebo-controlled study.
Headache
; 61(6): 927-935, 2021 06.
Artigo
em Inglês
| MEDLINE | ID: mdl-34153117
10.
Efficacy and safety of fremanezumab for episodic migraine prevention: Multicenter, randomized, double-blind, placebo-controlled, parallel-group trial in Japanese and Korean patients.
Headache
; 61(7): 1102-1111, 2021 07.
Artigo
em Inglês
| MEDLINE | ID: mdl-34323290
11.
Efficacy and safety of fremanezumab for chronic migraine prevention: Multicenter, randomized, double-blind, placebo-controlled, parallel-group trial in Japanese and Korean patients.
Headache
; 61(7): 1092-1101, 2021 07.
Artigo
em Inglês
| MEDLINE | ID: mdl-34324700
12.
Large-scale preparation and glycan characterization of sialylglycopeptide from bovine milk glycomacropeptide and its bifidogenic properties.
J Dairy Sci
; 104(2): 1433-1444, 2021 Feb.
Artigo
em Inglês
| MEDLINE | ID: mdl-33246621
13.
Disability, quality of life, productivity impairment and employer costs of migraine in the workplace.
J Headache Pain
; 22(1): 29, 2021 Apr 21.
Artigo
em Inglês
| MEDLINE | ID: mdl-33882816
14.
Efficacy and safety of erenumab in Japanese migraine patients with prior preventive treatment failure or concomitant preventive treatment: subgroup analyses of a phase 3, randomized trial.
J Headache Pain
; 22(1): 110, 2021 Sep 18.
Artigo
em Inglês
| MEDLINE | ID: mdl-34537006
15.
Effects of fremanezumab on the use of acute headache medication and associated symptoms of migraine in patients with episodic migraine.
Cephalalgia
; 40(5): 470-477, 2020 04.
Artigo
em Inglês
| MEDLINE | ID: mdl-31752521
16.
Vancouver Declaration II on Global Headache Patient Advocacy 2019.
Cephalalgia
; 40(10): 1017-1025, 2020 09.
Artigo
em Inglês
| MEDLINE | ID: mdl-32345038
17.
Treatment patterns and characteristics of patients with migraine in Japan: A retrospective analysis of health insurance claims data.
Cephalalgia
; 39(12): 1518-1534, 2019 Oct.
Artigo
em Inglês
| MEDLINE | ID: mdl-31154807
18.
Correction: Realworld experience with calcitonin generelated peptidetargeted antibodies for migraine prevention: a retrospective observational cohort study at two Japanese headache centers.
BMC Neurol
; 24(1): 157, 2024 May 09.
Artigo
em Inglês
| MEDLINE | ID: mdl-38724927
19.
A Randomized Phase 2 Study of Erenumab for the Prevention of Episodic Migraine in Japanese Adults.
Headache
; 59(10): 1731-1742, 2019 11.
Artigo
em Inglês
| MEDLINE | ID: mdl-31612482
20.
Vancouver Declaration on Global Headache Patient Advocacy 2018.
Cephalalgia
; 38(13): 1899-1909, 2018 11.
Artigo
em Inglês
| MEDLINE | ID: mdl-29882695